Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy (NCT06619860)

🧪 Interventions in This Study

• VX-993 (DRUG)
• Pregabalin (DRUG)
• Placebo (matched to pregabalin) (DRUG)
• Placebo (matched to VX-993) (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (47 Sites)

Showing the first 25 of 47 sites.

• Cullman Clinical Trials — Cullman, Alabama
• Trovare Clinical Research - Bakersfield CA — Bakersfield, California
• Eximia Research - San Diego — La Mesa, California
• Paradigm Clincial Research Centers, LLC., Wheat Ridge — Wheat Ridge, Colorado
• Accel Research - Deland — DeLand, Florida
• AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida
• Velocity Clinical Research - Hallandale Beach — Hallandale, Florida
• Health Awareness, Inc., Jupiter — Jupiter, Florida
• Suncoast Research Associates - Miami — Miami, Florida
• Innovation Medical Research Center - Palmetto — Palmetto Bay, Florida
• Health Awareness, Inc. - Port St. Lucie — Port Saint Lucie, Florida
• Atlanta Center for Medical Research — Atlanta, Georgia
• Accel Research - Decatur — Decatur, Georgia
• Velocity Clinical Research - Boise — Meridian, Idaho
• Healthcare Research Network - Flossmoor IL — Flossmoor, Illinois
• Quest Research Institute — Farmington Hills, Michigan
• Healthcare Research Network - Hazelwood MO — Hazelwood, Missouri
• Eximia Research - Raleigh — Raleigh, North Carolina
• Velocity Clinical Research - Cleveland — Beachwood, Ohio
• Velocity Clinical Research - Providence — East Greenwich, Rhode Island
• Clinical Trials of South Carolina - Berkeley - Moncks Corner — Moncks Corner, South Carolina
• Gadolin Research — Beaumont, Texas
• Velocity Clinical Research, Dallas — Dallas, Texas
• San Antonio Clinical Trials — San Antonio, Texas
• AMR Norfolk — Norfolk, Virginia

📞 Contact the Study Coordinator

Phone: (617) 341-6777

Email: medicalinfo@vrtx.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Diabetic Peripheral Neuropathic Pain

• Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) — Anniston, Alabama
• Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy — Anniston, Alabama
• MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP — Fredericksburg, Texas
• Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy — Birmingham, Alabama
• A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain — Birmingham, Alabama

Explore by condition: All Diabetic Peripheral Neuropathic Pain clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.